Nath Bio-Genes (India) Share Price
147.34-0.80 (-0.54%)
-10.52% past 1 Year
Corporate filings & documents
Announcements
Record Date
2 weeks agoRecord Date
2 weeks agoIntimation for record date
2 weeks agoIntimation for record date
2 weeks agoRecord Date for the AGM and Dividend
2 weeks agoRecord Date for the AGM and Dividend
2 weeks agoNotice of Annual General Meeting and Annual Report
2 weeks agoNotice of Annual General Meeting and Annual Report
2 weeks agoNotice of Annual General Meeting and Annual Report 2025-26
2 weeks agoNotice of Annual General Meeting and Annual Report 2025-26
2 weeks agoIntimation of Initiation of Forensic Audit
1 month agoIntimation of Initiation of Forensic Audit
1 month agoInvestor Presentation on Unaudited Financial Results as of 30th June 2026
1 month agoInvestor Presentation on Unaudited Financial Results as of 30th June 2026
1 month agoOutcome of Board Meeting: Unaudited Financial results as of 30th June 2026.
1 month agoOutcome of Board Meeting: Unaudited Financial results as of 30th June 2026.
1 month agoCompliance Certificate under Reg 74 (5) of SEBI (DP) Regulations
1 month agoCompliance Certificate under Reg 74 (5) of SEBI (DP) Regulations
1 month agoNath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 inter alia to consider and approve Unaudited financial results as of 30th June 2026
2 months agoNath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 inter alia to consider and approve Unaudited financial results as of 30th June 2026
2 months agoClosure of Trading Window
2 months agoClosure of Trading Window
2 months agoAnnual Secretarial Compliance Report for 31st March 2026.
3 months agoEarning Call Transcript held on 05th May 2026
4 months agoEarning Call Transcript held on 05th May 2026
4 months agoAudio Transcript of Concall held on 05th May 2026.
4 months agoAudio Transcript of Concall held on 05th May 2026.
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Nath Bio-Genes (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L01110MH1993PLC072842</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Dhiraj Rathi <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Amol Gupta <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 11/05/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Nath Bio-Genes (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L01110MH1993PLC072842</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Dhiraj Rathi <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Amol Gupta <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 11/05/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoInvestor Presentation on Financial Results as on 31st March 2026
4 months agoInvestor Presentation on Financial Results as on 31st March 2026
4 months agoOutcome of Board Meeting held on 04th May 2026
4 months agoOutcome of Board Meeting held on 04th May 2026
4 months agoAudited Financial Results as on 31st March 2026.
4 months agoAudited Financial Results as on 31st March 2026.
4 months agoIntimation for Earning Conference Call to be held on Tuesday 05th May 2026 at 04:00 PM.
4 months agoNath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve Financial Results as on 31st March 2026.
4 months agoNath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve Financial Results as on 31st March 2026.
4 months agoCompliance Certificate under SEBI (DP) Regulation.
5 months agoCompliance Certificate under SEBI (DP) Regulation.
5 months agoClosure of Trading Window
5 months agoClosure of Trading Window
5 months agoInvestor Presentation of Financial Results as on 31st December 2025
7 months agoIssue of Duplicate Share Certificate
7 months agoFinancial Results as on 31st December 2025.
7 months agoNath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve Financial Results as on 31st December 2025
7 months agoCompliance Certificate under Reg 74
8 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tapovan Paper and Board Mills Ltd & Others
8 months agoClosure of Trading window
8 months agoEarning Call Transcript
10 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Jul 2025
ConcallPresentation
Apr 2025
ConcallPresentation
Apr 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Oct 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Oct 2023
ConcallPresentation
Oct 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Apr 2023
ConcallPresentation
Apr 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Oct 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Jun 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Nov 2020
ConcallPresentation